EMILY BORDER: Open Payments
NPI 1659801207 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,873 in 94 payments from 29 companies in 2025. Trend: 2023 $1,831 · 2024 $1,661 · 2025 $1,873
Food & beverage: $1,873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $423 |
| TerSera Therapeutics LLC | 7 | $205 |
| Corcept Therapeutics | 7 | $173 |
| AstraZeneca Pharmaceuticals LP | 6 | $143 |
| Abbott Laboratories | 1 | $108 |
| Lundbeck LLC | 4 | $77 |
| Lilly USA, LLC | 4 | $66 |
| PFIZER INC. | 4 | $63 |
| Amgen Inc. | 4 | $59 |
| Axsome Therapeutics, Inc. | 2 | $56 |
Products named: VRAYLAR, Quzyttir, Korlym, UBRELVY, FARXIGA, FREESTYLE LIBRE 3, REXULTI, MOUNJARO.
Industry payments across ID — which companies pay providers there.
